Brawn Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Brawn Biotech	Munoth Communication	Nyssa Corporation
Operational Metrics
Financials
5 yr Average ROE	-23.35 %	-5.64 %	4.43 %
5yr average Equity Multiplier	2.88	1.22	1.19
5yr Average Asset Turnover Ratio	1.32	0.0	0.28
5yr Avg Net Profit Margin	-8.78 %	-343.72 %	13.95 %
Price to Book	1.89	0.42	0.22
P/E	0.0	0.0	0.0
5yr Avg Cash Conversion Cycle	109.48 Days	0.0	-168.3 Days
Inventory Days	105.98 Days	1515.13 Days	273.54 Days
Days Receivable	98.89 Days	0.0	128.67 Days
Days Payable	144.31 Days	41.24 Days	244.84 Days
5yr Average Interest Coverage Ratio	-119.79	-1.91	1496.53
5yr Avg ROCE	-15.28 %	-3.34 %	5.71 %
5yr Avg Operating Profit Margin	-9.69 %	-173.59 %	10.27 %
5 yr average Debt to Equity	0.0	0.16	0.0
5yr CAGR Net Profit	29.32 %	-7.4 %	-8.78 %
5yr Average Return on Assets	-7.81 %	-4.63 %	3.71 %
Shareholdings
Promoter Holding	53.39 %	30.48 %	0.0
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.33 %	0.0	-26.51 %
Change in Mutual Fund Holding (3 Yrs)	-0.24 %	0.0	0.0